Billable / Specific Code
ICD-10-CM Z16.341 is the diagnosis code for Resistance to single antimycobacterial drug. This code falls under the section "Resistance to antimicrobial drugs" within Chapter 21 — Factors influencing health status and contact with health services (Z00-Z99). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where Z16.341 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, Z16.341 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Z16.341 is the ICD-10-CM diagnosis code for "Resistance to single antimycobacterial drug". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of Z16.341 is Z16.34 ("Resistance to antimycobacterial drug(s)"). Z16.341 provides a more specific classification within this category.
Z16.341 is located in Section Z16 — "Resistance to antimicrobial drugs" within Chapter 21 of the ICD-10-CM Tabular List.
Use Z16.341 when the patients documented diagnosis matches "Resistance to single antimycobacterial drug" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Resistance to single antimycobacterial drug is Z16.341.
Yes, Z16.341 can be used as a primary diagnosis code since it is billable and specific.
Z16.341 is in Chapter 21 of the ICD-10-CM Tabular List.
Yes, Z16.341 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.